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on 5th Novem ber, 1965.
T h e  toxaemias of pregnancy form a discrete 
clinical syndrome which has been recognised as 
a disease of pregnancy almost since the practice 
of medicine began. T h eir aetiology and patho­
genesis are still unknown, and despite all the 
resources of modern m edicine, there is no 
treatm ent more effective than termination of 
the pregnancy —  a therapy which was dis­
covered several centuries B .C . There is no 
question that the nature of the condition pro­
vides one of the most fascinating problems of 
contem porary m edical research, but the urgency 
of gaining an understanding of the condition, 
and of evolving more effective therapy, is only- 
seen by considering the damage actually done 
by the disease, and the toll it still takes of 
maternal and infant life.
Present day m aternal m ortality figures are 
approxim ately 0.4 deaths per 1000 births. O f 
these, 18 %  are due to pregnancy toxaemia, 
which is second only to abortion as the largest 
single cause of maternal loss of life. For the 
child, the risk of stillbirth or early neonatal 
death is more than doubled in toxaemia, com ­
pared with normal pregnancy. It is possible to 
calculate that the loss of infant life in United 
Kingdom  which can be ascribed to toxaemia is 
about 3,000 deaths per annum . Fo r comparison, 
the total num ber of deaths in road accidents 
is about 7,000 per annum . Thus pregnancy 
toxaemia can be taken to be responsible for
nearly half as many deaths as our much- 
publicised traffic problem.
T h e actual incidence of the condition is 
difficult to assess, largely due to the problem  of 
establishing a generally acceptable set of 
diagnostic criteria. Average figures seem to 
suggest an incidence of 10 %  in first pregnancies, 
and 5%  in other pregnancies, but estimates as 
high as 25%  of all pregnancies have been 
quoted.1 Thus toxaemia of pregnancy is not 
sim ply a rare and interesting obstetric cur- 
iousity. It is a very real disease, responsible for 
considerable suffering, which deserves our close 
and critical appraisal.
D efin ition o f Toxaem ia
Toxaem ia of pregnancy is strictly a syndrome, 
not a disease. It is characterised by three fea­
tures —  hypertension, oedema and album in­
uria —  and these three features define the 
condition. However, they do not all need to be 
present to justify the diagnosis, since in mild 
cases, albuminuria may be absent or m inim al 
There arc also three possible origins or found­
ations for the toxaemia, and these are pre- 
eclampsia, essential hypertension and chronic 
nephritis.
T h e  classification becomes further com ­
plicated by the fact that quite apart from the 
toxaemia deriving from essential hypertension,
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patients with essential hypertension suffer an 
increased risk of developing a superimposed 
pre-eclamptie toxaemia. It is possible for a 
patient to have essential hypertension through­
out pregnancy without developing toxaemia, 
but the interesting question of whether the 
same may be said of pre-eclampsia cannot be 
answered.
T h e three conditions are com m only classed 
together since differentation between them, 
particularly in the late pregnancy, is often 
impossible, and since the treatment is largely 
identical, resolution is usually an academic 
point. There is, however, some basis for con­
sidering pre-eclampsia a discrete condition. In 
this type, the onset of toxaemia is often asymp­
tomatic and usually occurs after the thirtieth 
week of pregnancy. It may advance slowly or 
rapidly, and all but the mildest form will pro­
duce histological changes in the liver, kidney 
and placenta. Severe pre-eclampsia will lead 
to eclampsia. This pattern is characteristic of 
the pre-eclamptic type of toxaemia, and forms 
the basis for the statement that pre-eclampsia 
can occur in the patient with essential hyper­
tension. Subsequent discussion is confined to 
this type of toxaemia, since it seems possible 
that the basic pathology underlying it is also 
partly responsible for the production of the 
other toxaemias. However it should be 
emphasised that this is an assumption without 
solid foundation, and is not generally accepted.
Presentation of Pre-Eclampsia
Pre-eclampsia is a condition confined to 
pregnancy. T h e three primary features of 
toxaemia have been described, and in this form, 
the hypertension is usually the first to appear, 
followed by the fluid retention. Hypertension 
is com m only taken to be present when the 
blood pressure readies 140/90, but since the 
B.P . during the second trimester may normally 
be as low as 110 /70 , a sudden rise from this to 
130/85 could well represent the onset of 
toxaemia. It is therefore imperative that the 
blood pressure is recorded under identical con­
ditions each time the patient attends for ante­
natal care.
Fluid retention appears as a generalised 
oedema not to be confused with ankle-swelling, 
which is often present in apparently normal 
pregnancy. Tightness of the wedding-ring, or 
puffiness of the eyes is often the patients com­
plaint, and although a worsening ankle oedema 
must be held to be suggestive of toxaemia, 
evidence of a non-dependent oedema is a much
stronger clue. Album inira is a late sign of pre­
eclampsia and of little use diagnostically. Its 
degree does, however, carry considerable pro­
gnostic significance.
It is exceptional for a firm diagnosis of pre- 
eclampsia to be made on a single consultation. 
I f  the patient is attending regularly, a finding of 
a rise in blood pressure of 10  m m . diastolic, a 
com plaint of oedema, or a weight gain of 3 lb. 
in two weeks requires that the patient be seen 
again within two or three days. If the findings 
are confirmed, the diagnosis of toxaemia should 
be made, and therapeutic measures instituted. 
This may sound easy, but one must remember 
that ankle oedema is common in pregnancy; 
urinary infection (producing a trace of album in­
uria) is also common, and any anxiety will 
elevate the blood pressure. All three signs may 
thus co-exist without having any basis in 
toxaemia. Diagnosis is thus made from repeated 
routine checking of weight, blood pressure and 
the urine, and provided these tests are con­
scientiously carried out successful early detec­
tion can be achieved.
In the more severe ease of pre-eclampsia other 
manifestations of the toxaemia are added —  
namely headache, visual disturbances, epigastric 
pain and vomiting, and the condition may pro­
ceed to frank eclampsia with episodes of con­
vulsions, coma and then further convulsions. 
Even  if left untreated, not every case of pre­
eclampsia would proceed to eclampsia, but there 
is no way of predicting the course of the disease 
at the time of its onset and it is not possible to 
detect those destined for the severe type of 
toxaemia. Early diagnosis and careful observ­
ation is therefore necessary in all eases.
Pathology
T h e classical pathology of eclampsia is repre­
sented by changes in the liver and kidney which 
are quite characteristic. T h e  liver is said to 
undergo a periportal necrosis in the first 
instance, but this of course may extend to a 
massive necrosis with liver failure. A  mid- 
zonal necrosis is also seen in some cases. 
However it is the periportal lesion that is 
characteristic of eclampsia and it has been 
shown that it is caused by leakage of plasma 
into the space between the column of liver 
cells and its sheath of connective tissue, pro­
ducing compression and necrosis of the cells.2 
T h e  leakage is of blood rather than plasma in 
cases of haemorrhagic necrosis. M ultiple small 
haemorrhages arc also present beneath the 
capsule of the liver, and within the organ itself.
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Liver  In E c lam psia  show ing  per iporta l necrosis  (by 
c ourtesy  of Mr. L. P. Mackenzie) .
T h e kidney exhibits a characteristic glomer­
ular change with endothcliosis, swelling of the 
endothelial cells and oedema of the intcrsti- 
tium. N o abnormality of the basement 
membrane has been found. The placenta shows 
evidence of premature ageing with areas of 
infarction and fibrin nodes on the villi, but 
there are no changes characteristic of the 
disease. Elsewhere in the body, the lesions are 
those of capillary thrombosis and haemorrhage, 
and small haemorrhages are found generally.
Investigations into blood flow have shown 
that the kidney in pre-eclampsia has a low 
blood flow as a consequence of reduction in 
diameter of the afferent arteriole3 and there is 
some evidence that the uterine and placental 
arterial supply is also diminished.4 Blood flow 
to the liver, brain and limbs in pre-eclampsia 
has not been shown to differ from normal 
pregnancy, but in eclampsia, the cerebral blood 
flow is severely reduced5. Thus the pathology 
of the condition, together with the clinical 
manifestations appears to indicate that there is 
an arterial or arteriolar constriction in at least
kidney and placenta which has given rise to an 
increase in peripheral resistance, and so to 
hypertension. The capillary haemorrhages and 
liver changes can be regarded as secondary to 
hypertension, and the eclamptic convulsions arc 
almost certainly due to cerebral anoxia following 
arteriolar spasm.
The renal picture of a broadened pale renal 
cortex and congested medulla, with microscopy 
showing swollen glomeruli, immediately calls 
to mind the lesion of acute glomerulonephritis. 
T h e similarities, of course, go further— the 
presenting clinical signs in both conditions 
include hypertension, non-dependent oedema 
and albuminuria, and in severe glomerulone­
phritis, convulsions also occur. It is therefore 
necessary to bear in mind the possibility of 
pre-eclampsia having a related pathogenesis, 
and being essentially an immunological reaction 
to a sensitising agent derived from the foetus 
or placenta. However considerable difficulty 
arises when an attem pt is made to explain the 
relationship of the odcma to the hypertension, 
and in trying to correlate the degree of hyper­
tension with the extent of renal damage. 
Nevertheless, some support is produced for 
immunological explanations of pre-eclampsia 
and although these do not hold widespread 
popularity, they should not be overlooked.6-7
Aetiology
Before considering some of the other possible 
causes of pre-eclampsia, it is desirable to record 
some of the epidemiological findings that will 
have to be reconciled with any acceptable 
theory.
1. Pre-eclampsia appears more often in first 
pregnancies than in subsequent pregnancies.
2. Essential hypertension predisposes to it, 
and conversely, pre-eclampsia predisposes to 
the development of essential hypertension 
in later life.
3. M ultiple pregnancies carry a higher risk of 
pre-eclampsia than normal pregnancies.
4. H ydatiform mole predisposes to pre- 
eclampsia.
Death of the foetus in utero is usually 
associated with improvement in the con­
dition. but eclampsia can occur after 
delivery of the foetus and expulsion of the 
placenta.
There is no justification for assuming auto­
matically that since pre-eclampsia is a disease 
of pregnancy alone, its origins will be found in
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the products of conception. Gross changes 
occur in many organs during pregnancy, and 
these must be regarded with every bit as much 
suspicion as the uterine contents. Nevertheless, 
with some grounds, many workers believe in 
the production of a pressor substance by the 
placenta, and the liberation of this material 
into the maternal circulation, causing the 
hypertension. B y analogy with the kidney, the 
concept of the “ G oldblatt placenta”  has arisen, 
but positive evidence of a humoral vasopressor 
material liberated as a result of uterine or 
placental ischaemia is sadly lacking. It is known 
that the plasma renin level is elevated during 
pregnancy, but there is no evidence that the 
uterus or placenta is responsible for this, nor 
that the elevation is greater in toxaemic patients 
than in normal pregnancy.8 Investigation of 
the steroid hormones in toxaemia has given 
conflicting results, but the general feeling seems 
to support an elevation of the 17  - hydroxy- 
steroid output, with a reduction in the adreno­
cortical response to A .C .T .H . even lower than 
in normal pregnancy. 910 It has been suggested 
that the ratio of m ineralocorticoid/glucocorti- 
coid hormones is elevated in toxaemia11 but 
current work all seems to refute the proposal 
that aldosterone production in toxaemia is 
higher than in normal pregnancy12'13 An 
elevation of aldosterone output would, of 
course, be an excellent preliminary to rational­
ising the salt and water retention.
There are also published works on the 
presence of an anti-diuretic material found in 
pre-eclamptic patients sera, suggesting a 
posterior pituitary-like hormone as the causative 
agent, but in spite of the natural tendency to 
think of the posterior pituitary when concerned 
with a problem of vasoconstriction and water 
retention, this too has led nowhere.14-15
Recently, great interest has centred on the 
monoamines, and in particular 5 - hydroxytry- 
ptamine. T h e  discovery of reduced monoamine 
oxidase activity in the placentae of pre­
eclamptic patients led to the theory that 
;  - hydroxytryptam ine accumulated in these 
patients, producing vasoconstriction.16 Since 
monoamine oxidase activity is known to be 
related to oxygen tension17 this vasoconstriction, 
by lowering placental oxygen tension, would 
reduce m onoam ine oxidase activity still further 
and so a vicious circle would be set up. However 
the monoamine oxidase inhibitor drugs do not 
appear to precipitate pre-eclampsia, as they 
might be expected to do if this theory were 
valid, and there is no positive evidence to 
support the contention that these drugs are
unable to cross the “ placental barrier” . In any 
case, a paper published recently failed to con­
firm the basic finding of reduced monoamine 
oxidase levels.18
Although pre-eclampsia amply justifies its 
title of “ the disease of theories”  there is no 
question that current thought is focused on a 
humoral origin of the hypertension, related to 
ischaemia of the uterus or its contents. H ow ­
ever, although the idea is not new1920 the 
importance of variation in sensitivity of the 
blood vessels to the known pressor agents does 
not seem to have received the intense experi­
mental investigation that it warrants. There 
are two possibilities.
1. T h at the blood vessels in the pre-eclamptic 
patient are inherently more sensitive to a 
pressor material produced by the uterus or 
its contents in all pregnancies.
2. T h at the uterus in pre-eclampsia is liber­
ating into the maternal circulation a material 
which is not in itself a pressor substance, 
but increases the sensitivity of the blood 
vessels to the known pressor materials. T h e 
possible im plication of m onoam ine oxidase 
in the aetiology of pre-eclampsia renders 
one very conscious of the precedent pro­
vided by the action of the anti cholines- 
terase drugs at the neuromuscular junction.
There is no question that the influences —  
notably endocrine influences —  on the sensi­
tivity of blood vessels to substances such as the 
catechol amines, serotorin, angiatensin and the 
posterior pituitary hormones are worthy of 
intense investigation. Progress in research into 
essential hypertension must be closely followed 
by those interested in pre-eclampsia, and it 
could be that the two conditions have much in 
common.
Management of Pre-Eclampsia
A  woman admitted to hospital with mild or 
moderate pre-eclampsia is usually confined to 
bed, given a sedative such as phenobarbitone or 
amytal, and nothing more. Some obstetricians 
also restrict the patient’s salt intake. Com plete 
bed rest and sedation arc designed to provide 
the best environment for peace of mind and a 
general absence of the emotional strains of daily 
life, but of course, steps must also be taken to 
isolate the patient from any sources of personal 
worry if these exist. In severe cases a check on 
urinary output is necessary, but in the majority 
observation of blood pressure and weight will 
show the success of these measures. Bed rest
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alone, by virtue of being a horizontal position, 
will reduce ankle oedema, so this must not be 
regarded as an index of the response to treat­
ment.
F o r the m inority of patients in whom  this 
regime is unsatisfactory, the use of hypotensive 
drugs m ay be necessary. T h e  rauwolfia and 
veratrum alkaloids have been used —  reserpine 
in particular is a good drug for the milder 
degrees of hypertension. Severe cases will 
require the use of guanethidine in conjunction 
with a thiazide diuretic, since it is im perative to 
bring the blood pressure down to less dangerous 
levels. O ne hopes that the risk of eclampsia is 
correspondingly dim inished. However the effect 
of the more potent anti-hypertensive and 
diuretic drugs on the prognosis for the child 
has been disappointing, and it appears that this 
is largely due to their small effect on uterine 
blood flow and therefore on placental supply.
T h e  obstetric managem ent of pre-eclampsia 
can demand agonising decisions. It may be said 
that as pregnancy advances to term, pre- 
eclampsia will tend to become more severe, and 
the ageing placenta will fail to meet the require­
ments of the foetus. On the other hand, the 
foetus in pre-eclampsia is com m only smaller 
than average, and early induction of labour is 
liable to produce a very small baby, exposed to 
all the risks of prematurity. T h e  problem is 
therefore one of when to induce, and no hard 
and fast rules are available. Assessment of the 
baby’s size is usually carried out clinically and 
some idea of placental function may be gained 
from the urinary pregnanediol output, but 
experience remains the best foundation for 
m aking the decision. Induction before 36 weeks 
will be necessary in patients with severe hyper­
tension and albuminuria, since here the 
prognosis for the infant is better than that for
the foetus in utero. T h e  correlation between 
album inuria and prognosis has been m entioned 
earlier. Nevertheless, the great m ajority of cases 
can be left to 38 or 39 weeks, when induction 
should usually be carried out. T h e  conventional 
methods of induction are used, and this is not 
the place to discuss the relative merits of these. 
But it is not out of place to add that the general 
rule of failed oxytocin induction being an 
indication for Caesarian section is in n o  way 
invalidated by toxaemia.
T h e  m anagement of im m inent or frank 
eclampsia is a standard procedure and there is 
little to be gained from reiterating it here. It is 
obvious that pre-eclampsia is a condition where 
it is vital under present circumstances to con­
centrate on early diagnosis and the prevention 
of eclampsia, rather than the treatment of 
eclampsia itself. Surveys of maternal m ortality 
in toxaemia indicate that nearly 50%  of the 
deaths could have been avoided with early 
diagnosis and treatment. T h e  size of this 
avoidable m ortality is in part due to patients 
who, for one reason or another, have failed to 
seek medical attention, but it still represents an 
unnecessary loss of life, and the importance of 
every pregnant woman receiving anti-natal care 
must be firm ly impressed on the general popul­
ation. Nevertheless, even with the best care 
available, the treatment of toxaemia seems 
inadequate for the mid-twentieth century, and 
it looks as if permutations and modifications of 
present methods will provide nothing but trivial 
improvement. It is likely that the solution will 
eventually come from the endocrinologist who 
is investigating the problem at the fundamental 
level, and one would hope that from this, an 
efficient therapy will be developed to banish 
this disease of theories from our maternity 
hospitals.
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